The Scots Health Exec have just refused to licence a drug for prostate cancer. Prostate cancer kills around 10,000 men a year. The cost of Taxotere ? £7,500. And Taxotere IS licensed for use with prostate cancer, unlike Herceptin was.
Men’s health being ignored again then. Oh sorry .. that’s old news.